Advancing Research on Care and Outcome Measurement (ARCOM) – LOI

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with your unit

Memorial Deadline: No RGCS review required for the LOI

External Deadline: Wednesday 5th, May 2021


Description

Leveraging an Interdisciplinary Consortium to Improve Care and Outcomes for Persons living with Alzheimer’s and Dementia (LINC-AD)is a five-year consortium funded by the National Institutes of Health(NIH) that is undertaking a series of high-impact activities to usher in the next phase of psychosocial research in Alzheimer’s disease and all other dementia. Recognizing the importance of an interdisciplinary approach, the consortium is composed of researchers as well as stakeholders including individuals with dementia and their care partners,family members and long-term and community-based providers.The consortium has identified a pressing need for process and outcome measures of relevance to stakeholders and sensitive to change in order to generate a set of common and meaningful measurement tools for cross-study comparisons. LINC-AD’s overarching goal is to broaden interdisciplinary interest in measuring person-centered outcomes that foster a constructive balance between strengths and deficits assessment; add a new emphasis on evidence-based tools to guide structures and processes of care; and provide a novel conceptual framework to inform measurement related to care.

Through these goals, LINC-AD aims to evaluate existing outcome measures and care tools within each of the nine domains of the Dementia Care Practice Recommendations to (a) establish criteria for evaluating measures and tools; (b) identify measurement priority areas; and (c) review existing measures and tools and identify gaps. As a partner of LINC-AD, the Alzheimer’s Association International Research Grant Program is committed to identifying opportunities that address gaps and provide funding for pilot projects.The Advancing Research on Care and Outcome Measurement(ARCOM)funding program, in collaboration with LINC-AD, is the first collaborative program to address these care and outcome measures. More information on LINC-AD: https://alz.org/linc-ad/overview.asp

The Alzheimer’s Association and Brain Canada Foundation are pleased to partner on any successful application from a Canadian-led team.PROGRAM OBJECTIVE The ARCOM funding program aims to address significant gaps in care and outcome measurement, and provide an opportunity to advance research so that care providers can ensure that they are implementing evidence-based practices (using measures to guide care provision) and achieving desired outcomes (using measures to assess outcomes). Work funded through ARCOM must directly advance research projects focused on development of new—and/or validation of previously developed—measures of care and outcomes where measurement gaps exist, and evaluation of the use of such measures in improving care and outcomes across diverse and underrepresented populations and stages of dementia, and in various settings. Investigators awarded through ACROM will be expected to engage with LINC-AD to share research activities and advances as a part of the overall consortium.

Additional information can be found here.


Funding Sources

Brain Canada Foundation



This opportunity was posted by: RGCS

Last modified: April 6, 2021